Pancreatic Cancer Research

ResearcherUniversity of Occupational and Environmental Health JapanNo recent work listed

Xiaobo Cheng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110721859. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 4 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper

Papers 9

  1. Negative regulation between the expression levels of receptor for hyaluronic acid-mediated motility and hyaluronan leads to cell migration in pancreatic cancer. Co-author DOI 10.3892/ol.2020.12060↗
  2. 4-Methylumbelliferone inhibits enhanced hyaluronan synthesis and cell migration in pancreatic cancer cells in response to tumor-stromal interactions. Co-author DOI 10.3892/ol.2018.8147↗
  3. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2016.12.007↗
  4. A novel epigenetic mechanism regulating hyaluronan production in pancreatic cancer cells. Co-author DOI 10.1007/s10585-015-9771-9↗
  5. Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.apsb.2016.01.002↗
  6. Increased Expression of HYAL1 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000670↗
  7. Hyaluronan stimulates pancreatic cancer cell motility. Co-author DOI 10.18632/oncotarget.6617↗
  8. Receptor for Hyaluronic Acid-Mediated Motility is Associated with Poor Survival in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.12990↗
  9. Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0080765↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Norihiro Sato · 9 shared papers, 2013–2020 · strength 0.70
  2. Shiro Kohi · 8 shared papers, 2013–2018 · strength 0.60
  3. Atsuhiro Koga · 7 shared papers, 2015–2018 · strength 0.55
  4. Keiji Hirata · 7 shared papers, 2015–2018 · strength 0.55
  5. Hanxing Tong · 1 shared paper, 2020 · strength 0.11
  6. Lili Wu · 1 shared paper, 2020 · strength 0.11
  7. Yuhong Zhou · 1 shared paper, 2020 · strength 0.11
  8. Masanori Hisaoka · 1 shared paper, 2017 · strength 0.08
  9. Koji Yamaguchi · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.